A Hidden Chemical Clock May Be Ticking Inside Plastic Medical Tubes
Plastic medical tubing is often treated as an inert part of modern healthcare: a transparent conduit carrying medicines, nutrients and fluids into the body. But the flexible poly(vinyl chloride), or PVC, used in many infusion lines is not made flexible by the polymer alone. It contains plasticisers—small molecules blended into the plastic to make it bend without breaking—and those additives can gradually leave the material and enter the solutions flowing through it. A new laboratory study has now revealed that three widely used alternatives to the controversial plasticiser DEHP can behave dramatically differently after they enter a liquid. Under strongly alkaline, accelerated conditions, one compound vanished in minutes, another in hours, while a third persisted for weeks. The result does not show that patients are being exposed to dangerous levels of degradation products, but it highlights a neglected stage in the life cycle of medical-device additives: what happens after a plasticiser has already migrated into a pharmaceutical solution.
PVC is inexpensive, mechanically durable and resistant to many chemicals, which explains its continued use in medical devices ranging from blood bags and catheters to infusion tubing. For decades, its flexibility was commonly achieved with di(2-ethylhexyl) phthalate, better known as DEHP. Concerns about DEHP migration and possible toxicological effects have driven regulatory restrictions, particularly in Europe, encouraging manufacturers to adopt compounds with more favourable safety profiles. Three of the most important replacements are di(2-ethylhexyl) terephthalate, or DEHT; tris(2-ethylhexyl) trimellitate, or TOTM; and diisononyl cyclohexane-1,2-dicarboxylate, or DINCH. Previous research has established that these alternatives can migrate from PVC into pharmaceutical formulations under experimental and clinical conditions. The new work asks a different question: once released into solution, how chemically stable are the additives themselves?
To isolate that question, the researchers did not extract plasticisers from PVC tubing. Instead, they dissolved analytical-grade DEHT, TOTM and DINCH directly in HPLC-grade methanol, creating a controlled solution-phase model independent of diffusion from a polymer matrix. The solutions were adjusted to apparent pH values between 2.1 and 11.9 using hydrochloric acid or sodium hydroxide and held at 35 °C for as long as 28 to 34 days. The most alkaline condition was deliberately harsher than the conditions normally encountered in pharmaceutical formulations. It was designed as a worst-case stress test, accelerating ester cleavage and making it easier to distinguish the compounds’ intrinsic chemical susceptibilities. Because methanol has different solvent properties from water, and because sodium hydroxide was used to create the alkaline environment, the measured values are apparent pH values rather than directly transferable aqueous pH measurements. The experiment therefore cannot be read as a forecast of what will happen inside a patient or an infusion line under ordinary clinical conditions.
The chemistry behind the test is straightforward in outline but complex in its molecular details. Each of the compounds contains ester bonds, in which an organic acid component is linked to an alcohol-derived group. Under alkaline conditions, hydroxide or another nucleophile can attack the ester’s carbonyl carbon, producing cleavage products in a process commonly described as hydrolysis or saponification. In methanol, however, methanol-assisted transesterification cannot be excluded, and the chromatographic method was not capable of separating these possible reaction pathways. The molecules also differ in their architecture. DEHT has two ester groups attached to an aromatic terephthalate core. TOTM has three ester groups attached to an aromatic trimellitate core. DINCH also has two ester functions, but its central structure is a cycloaliphatic cyclohexane-1,2-dicarboxylate rather than an aromatic ring system. These differences can affect the electronic environment around the carbonyls, their accessibility to nucleophiles, molecular shape and solvation—factors that may determine how rapidly cleavage occurs.
The team tracked the parent compounds using reversed-phase high-performance liquid chromatography with diode-array detection, or RP-HPLC-DAD. This technique separates molecules according to their interactions with a nonpolar stationary phase and a flowing solvent mixture, then detects them through their ultraviolet absorbance. A C8 column separated the three parent plasticisers, which appeared at retention times of about 7.5 minutes for DEHT, 10.1 minutes for DINCH and 15.1 minutes for TOTM. Measurements at 220 nanometres allowed the researchers to monitor all three compounds and newly emerging chromatographic peaks in the same analytical run. The method showed excellent linearity, with calibration coefficients above 0.999, and parent-compound peak-area variation below 5 percent. Those results support the reliability of the central observation—loss of the original plasticiser signal—although they do not identify every molecule formed during the reactions.
The contrast among the additives was striking at apparent pH 11.9. TOTM was the fastest to disappear, with an estimated half-life of approximately 12.1 minutes. DEHT followed with a half-life of about 161.6 minutes, or 2.7 hours. DINCH was vastly more persistent: its apparent half-life was 18.62 days, and 35.25 percent of its initial chromatographic signal was still present after 28 days. The overall stability ranking under this extreme alkaline condition was therefore DINCH, followed by DEHT, followed by TOTM. In less alkaline solutions, the picture was more nuanced. TOTM was more resistant than DEHT under moderately alkaline conditions, but its degradation accelerated sharply at the highest apparent pH tested. DEHT began showing measurable changes above apparent pH 10, while DINCH showed no detectable degradation over the study period from apparent pH 7.0 through 11.0. None of the three compounds showed significant parent-compound loss under acidic conditions or at the neutral control condition of apparent pH 7.0.
The chromatograms also offered clues about how the molecules broke apart. As DEHT declined under alkaline conditions, a new peak appeared at roughly 3.9 minutes. At higher apparent pH, another emerged near 2.7 minutes, followed by a transient third signal. The first product rose and then fell, producing a bell-shaped time profile characteristic of an intermediate that forms from the parent and is subsequently transformed. TOTM generated several additional peaks, appearing at approximately 7.5, 6.3 and 3.5 minutes as its parent peak disappeared. That pattern is compatible with successive cleavage of its three ester groups, passing through diester and monoester intermediates before producing smaller fragments. DINCH produced fewer additional peaks, which is consistent with its slower overall transformation. The researchers provisionally labelled these signals DP1, DP2 and DP3, but did not claim definitive molecular identities.
The study’s kinetic analysis added another layer of comparison. Parent DEHT and DINCH disappearance at apparent pH 11.9 was adequately described by an apparent first-order model, in which the rate of loss depends on the amount of parent compound remaining. For DEHT, the apparent rate constant was 6.177 per day, with an adjusted coefficient of determination of 0.9989 and a half-life of 161.6 minutes. DINCH had a much smaller apparent rate constant of 0.03722 per day. TOTM disappeared too rapidly for a robust comparison of zero-, first- and second-order models across equivalent sampling intervals, so its half-life is best regarded as a descriptive estimate rather than a fully resolved kinetic constant. These parameters apply only to the specific methanolic medium, sodium-hydroxide adjustment and 35 °C temperature used in the experiments. They should not be extrapolated directly to aqueous drug solutions, physiological fluids, room-temperature storage or the interior of a PVC device.
The findings may nevertheless matter for how researchers evaluate medical-device materials. Plasticiser exposure is not a single event but a chain of processes: an additive must first move through the PVC matrix, partition into the contacting formulation, remain present in the solution and possibly undergo chemical transformation. The present experiment examined only the final part of that sequence. It did not measure migration from tubing, the influence of flow rate, contact with particular medicines, sterilisation, long-term storage, oxidative reactions, enzymatic breakdown or the biological effects of any products. Nor did it establish a complete mass balance, because the additional peaks lacked authentic standards and compound-specific response factors. Retention times and ultraviolet spectra alone cannot prove that a peak is mono(2-ethylhexyl) terephthalate, terephthalic acid, a DINCH monoester such as MINCH or any other proposed product. Confirming those assignments would require techniques such as liquid chromatography–tandem mass spectrometry, nuclear magnetic resonance spectroscopy and authentic reference materials.
The most important message is therefore comparative rather than alarmist. A substitute plasticiser may be less problematic than DEHP in one safety dimension yet possess a different chemical fate once it leaves the polymer. DINCH’s persistence in the accelerated test could mean greater stability in some solution environments, but persistence alone does not establish safety; the amount that migrates, the formulation it enters and the toxicity of both parent and transformed compounds remain essential questions. Conversely, rapid disappearance of TOTM or DEHT under harsh alkaline conditions does not demonstrate that they degrade rapidly during clinical infusion. The researchers describe their experiment as a complementary screening framework, not a stand-alone basis for selecting medical-device additives. Future studies will need to combine realistic extractables-and-leachables testing with dynamic flow experiments, drug compatibility measurements, product identification and toxicological assessment. For now, the work shows that the chemistry of “safer” plasticisers does not end when they escape the plastic: in the right—or wrong—chemical environment, each additive carries its own molecular clock.
Subject of Research: Solution-phase alkaline degradation and comparative stability of DEHT, TOTM and DINCH plasticisers used in PVC medical devices
Article Title: Comparative solution-phase stability of alternative PVC plasticisers under accelerated alkaline conditions
Article References: Original research article on ScienceDirect
Image Credits: AI Generated
DOI: Not provided
Keywords: PVC medical devices, plasticiser migration, DEHT, TOTM, DINCH, alkaline ester cleavage, degradation kinetics, RP-HPLC-DAD
Tags: accelerated aging of PVC medical tubingalternative plasticizers in healthcarechemical degradation of plasticiserschemical stability of plasticisers under alkaline conditionseffects of plasticiser degradation on drug deliveryevaluation of plasticiser alternatives in PVChydrolytic stability of PVC additivesimpact of plasticiser migration on patient safetylongevity of plasticisers in medical applicationsmedical device plasticizer migrationplasticiser leaching in infusion linesPVC plasticizer stability
